Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy-Reference-Cited by-同舟云学术

Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Published:2012-11-08 Issue:11 Volume:8 Page:e1003014
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Perkins Molly R.,Ryschkewitsch Caroline,Liebner Julia C.,Monaco Maria Chiara G.,Himelfarb Danielle,Ireland Sara,Roque Annelys,Edward Heather L.,Jensen Peter N.,Remington Gina,Abraham Thomas,Abraham Jaspreet,Greenberg Benjamin,Kaufman Charles,LaGanke Chris,Monson Nancy L.,Xu Xiaoning,Frohman Elliot,Major Eugene O.,Douek Daniel C.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference41 articles.

1. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy;BL Padgett;Lancet,1971

2. Risk of natalizumab-associated progressive multifocal leukoencephalopathy;G Bloomgren;N Engl J Med,2012

3. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring;L Kappos;Lancet Neurol,2011

4. The changing landscape of progressive multifocal leukoencephalopathy;S Kedar;Curr Infect Dis Rep,2011

5. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells;P Kivisakk;Neurology,2009

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. John Cunningham Virus and Progressive Multifocal Leukoencephalopathy: A Falsely Played Diagnosis;Diseases;2024-05-13

2. Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report;Therapeutic Advances in Hematology;2023-01

3. Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review;Journal of the Neurological Sciences;2022-12

4. T cell deficiency precipitates antibody evasion and emergence of neurovirulent polyomavirus;eLife;2022-11-07

5. T Cell Deficiency Precipitates Antibody Evasion and Emergence of Neurovirulent Polyomavirus;2022-02-25